MedTrace Logo

ASH Research Collaborative Data Hub

NCT05775224 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-06-17

No results posted yet for this study

Summary

Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from basic, translational, clinical and population perspectives offer the possibility of improving the way that these diseases are treated, and the outcomes experienced by patients. A repository that aggregates and validates this data across institutions and other practice settings is needed in order to identify variation in care, new findings, and further research.

Conditions

Sponsors & Collaborators

  • ASH Research Collaborative

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-29
Primary Completion
2099-04-29
Completion
2099-04-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05775224 on ClinicalTrials.gov